Pembrolizumab induced pericardial tamponade: A case report
Key Clinical Message The occurrence of a large pericardial effusion is not a commonly noted adverse event associated with pembrolizumab and our report demonstrates that a rapid development can be diagnosed with close monitoring and triage to acute medical settings. Abstract Pembrolizumab is an immun...
| Published in: | Clinical Case Reports |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-05-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.7298 |